companydata.dkcompanydata.dk

MJJ Biotech A/S: Financial statements 2024

CVR: 43227831

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

MJJ Biotech A/S (CVR 43227831) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,571,784 and a net result of DKK -2,535,681 compared with DKK -137,711 the year before. That is a decrease of 66% compared with the year before. Equity in the 2024 report amounted to DKK -1,853,083. The company had 4 employees in the financial year.

Gross Profit
DKK 2,571,784
Profit/Loss
DKK -2,535,681
Equity
DKK -1,853,083
Total Assets
DKK 452,831
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-2.6M-2.5M-1.9M4
2023-7.6M-138K683K11

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

MJJ Biotech A/S: The 2023 annual report is outJun 28, 2024

MJJ Biotech A/S has published its annual report for 2023. Gross profit came to DKK 7,554,176, and the net result was DKK -137,711.

About MJJ Biotech A/S

MJJ Biotech A/S was a Danish company of the type Aktieselskab based in Odense SØ, founded in 2022. The company has been dissolved on 4 February 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees (2024). In 2024, the company reported a gross profit of DKK 2,571,784 and a net result of DKK -2,535,681 compared with DKK -137,711 the year before. Equity in the 2024 report amounted to DKK -1,853,083.

Source: annual report 2024, Danish Business Authority

Other financial years